Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 3 | -7.63K | 100% | $1.01 | -$7.67K |
Net | -3 | -7.63K | -100% | -$7.67K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Cantex Pharmaceuticals, Inc. | 10%+ Owner | $3.34M | Sep 14, 2021 | ||
Fred A. Middleton | Director | $695K | Oct 28, 2024 | ||
Michael T. Andriole | PRESIDENT AND CEO, Director | $383K | -$2.87K | -0.74% | Aug 8, 2024 |
Michael Alrutz | Svp And General Counsel | $161K | Feb 1, 2024 | ||
David Jakeman | Vp Of Finance And Accounting | $147K | -$2.78K | -1.85% | Feb 14, 2024 |
Michelle LaSpaluto | Chief Financial Officer | $116K | -$2.02K | -1.72% | Feb 14, 2024 |
Allen S. Melemed | Chief Medical Officer | $82.6K | Feb 1, 2024 | ||
Patrick Machado | Director | Jun 9, 2023 | |||
Thomas J. Riga | COO and CCO | Nov 16, 2023 | |||
Robert J. Meyer | Director | Jun 20, 2024 | |||
Michael A. Sherman | Chief Executive Officer, Director | Jun 20, 2024 | |||
Marc D. Kozin | Director | Jun 20, 2024 | |||
Martha J. Demski | Director | Jun 20, 2024 | |||
Pratik S. Multani | Director | Jun 20, 2024 | |||
Lisa Lynn Decker | Director | Jun 20, 2024 | |||
Catherine Gilliss | Director | Jun 9, 2023 | |||
Victoria Vakiener | Director | Jun 20, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|